Related Experiment Video
Updated: Sep 3, 2026
Percutaneous Endoscopic Unilateral-Approach Bilateral Decompression for Lumbar Spinal Stenosis
Published on: February 9, 2024
Familial risks of hospital-treated spinal stenosis in first-, second-, and third-degree relatives: a nationwide
Christian Anker-Hansen1, MirNabi Pirouzifard2, Jan Sundquist1
1Center for Primary Health Care Research, Lund University, Region Skåne, Building 28, Floor 11, Entrance 72, Malmö SE-205 02, Sweden; University Clinic Primary Care, Skåne University Hospital, SE-221 85, Entregatan 7, Lund, Region Skåne, Sweden.
Background Context:
Spinal stenosis (SS) has a multifactorial background.
Purpose:
This nationwide study aimed to determine the familial risks of hospital-treated SS in first-, second-, and third-degree relatives in Sweden.
Study Design:
The Swedish Multigeneration Register was linked to the National Patient Register to investigate the heredity of hospital-treated SS between 1997 and 2018.
Patient Sample:
Offspring born to Swedish-born parents were included.
Outcome Measures:
Familial hazard ratios for SS were calculated for relatives of individuals who had a diagnosis of SS compared with relatives of individuals unaffected by SS as the reference group. The adjusted familial hazard ratios with 95% confidence interval (CI) were determined for SS among pairs of twins, full-siblings, half-siblings, and cousins.
Methods:
Adjustments were made for birth year, sex, education, occupation, and comorbidities, including amyloidosis.
Results:
A total of 6,548,565 individuals (48.77% women) were included with a mean age of 41 years (range 0-87 years) at the end of follow-up. A total of 36,958 (0.56%) individuals were affected with hospital-treated SS. The afHR for SS were for twins 5.12 (95% CI 3.33-7.89), siblings 2.47 (95% CI 2.35-2.60), half-siblings 1.49 (95% CI 1.28-1.73), and cousins 1.10 (95% CI 0.85-1.43). Among full-siblings, adjusted familial hazard ratios were 5.38 (95% CI 2.02-14.33) for cervical SS and 3.01 (95% CI 2.69-3.67) for lumbar SS. A total of 0.27% SS patients had amyloidosis. Patients with amyloidosis had an adjusted hazard ratio of 2.03 (95% CI 1.67-2.48) for SS.
Conclusions:
Heredity is associated with higher risk of hospital-treated SS in the Swedish population.
